These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26043678)

  • 1. Effect of aflibercept in patients with age-related macular degeneration.
    Okuma H; Mimura T; Goto M; Kamei Y; Yoshida M; Kondo A; Matsubara M
    Int Ophthalmol; 2016 Apr; 36(2):159-69. PubMed ID: 26043678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
    Hosokawa MM; Ouchi C; Shiode Y; Kimura S; Matoba R; Morita T; Morizane Y
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3099-3107. PubMed ID: 38625447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration.
    Saito M; Kano M; Itagaki K; Sekiryu T
    Jpn J Ophthalmol; 2017 Jan; 61(1):74-83. PubMed ID: 27660164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
    Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
    Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration.
    Inoue M; Yamane S; Sato S; Sakamaki K; Arakawa A; Kadonosono K
    Am J Ophthalmol; 2016 Sep; 169():95-103. PubMed ID: 27320059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE INFLUENCE OF VITREOMACULAR ADHESION ON OUTCOMES AFTER AFLIBERCEPT THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    McKibbin MA; Suter CA; Willis TA
    Retina; 2015 Oct; 35(10):1951-6. PubMed ID: 25932561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept.
    Hara C; Wakabayashi T; Fukushima Y; Sayanagi K; Kawasaki R; Sato S; Sakaguchi H; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2559-2569. PubMed ID: 31482277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
    Shin JY; Choi M; Chung B; Byeon SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of aflibercept in treatment-naive choroidal neovascularization of wet age-related macular degeneration.
    Gambon R; Barthelmes D; Amstutz C; Fleischhauer J; Kurz-Levin M; Zweifel S
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):423-6. PubMed ID: 24771183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal aflibercept for ranibizumab-resistant exudative age-related macular degeneration with choroidal vascular hyperpermeability.
    Nomura Y; Yanagi Y
    Jpn J Ophthalmol; 2015 Jul; 59(4):261-5. PubMed ID: 25983109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
    Dugel PU; Jaffe GJ; Sallstig P; Warburton J; Weichselberger A; Wieland M; Singerman L
    Ophthalmology; 2017 Sep; 124(9):1296-1304. PubMed ID: 28551167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Kawasaki R; Sekiryu T; Okada AA; Iida T
    Am J Ophthalmol; 2015 Apr; 159(4):627-33. PubMed ID: 25555799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration.
    Zinkernagel MS; Wolf S; Ebneter A
    Ophthalmologica; 2016; 235(1):42-8. PubMed ID: 26540259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
    Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
    Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration.
    Braimah IZ; Stewart M; Videkar C; Dedhia CJ; Chhablani J;
    Br J Ophthalmol; 2017 Sep; 101(9):1201-1205. PubMed ID: 28119292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.